Top 10 Tramadol (Ultram) Generic Manufacturers in Brazil

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Brazil has seen significant growth in recent years, with an increasing demand for generic medications like Tramadol (Ultram). As one of the top markets for generic drugs in Latin America, Brazil has a number of key players in the production and distribution of Tramadol. In 2020, Brazil’s pharmaceutical market was valued at over $30 billion, with generic drugs accounting for a significant portion of the total market share.

Top 10 Tramadol (Ultram) Generic Manufacturers in Brazil:

1. Teuto Pharmaceutical Industries
Teuto Pharmaceutical Industries is one of the leading manufacturers of generic drugs in Brazil, including Tramadol. With a production volume of over 10 million units annually, Teuto has established itself as a key player in the Brazilian pharmaceutical market.

2. EMS Pharmaceutical
EMS Pharmaceutical is another major player in the Brazilian pharmaceutical industry, producing a wide range of generic medications, including Tramadol. EMS has a strong presence in the market, with a market share of over 15% in the generic drug segment.

3. Eurofarma
Eurofarma is a well-known pharmaceutical company in Brazil, producing a variety of generic drugs, including Tramadol. With exports to over 20 countries worldwide, Eurofarma has established itself as a key player in the global pharmaceutical market.

4. Aché Laboratórios Farmacêuticos
Aché Laboratórios Farmacêuticos is a leading pharmaceutical company in Brazil, with a focus on research and development of generic medications. Aché produces a significant amount of Tramadol annually, catering to the growing demand for generic drugs in the Brazilian market.

5. Biolab Farmacêutica
Biolab Farmacêutica is a key player in the Brazilian pharmaceutical industry, producing a wide range of generic medications, including Tramadol. With a strong distribution network across Brazil, Biolab has a significant market presence in the generic drug segment.

6. Cristália Produtos Químicos Farmacêuticos
Cristália Produtos Químicos Farmacêuticos is a leading manufacturer of generic drugs in Brazil, including Tramadol. With a focus on quality and innovation, Cristália has established itself as a trusted name in the Brazilian pharmaceutical market.

7. EMS Sigma Pharma
EMS Sigma Pharma is a subsidiary of EMS Pharmaceutical, specializing in the production of generic medications, including Tramadol. With a production volume of over 5 million units annually, EMS Sigma Pharma plays a key role in meeting the demand for generic drugs in Brazil.

8. Hypermarcas
Hypermarcas is a major player in the Brazilian pharmaceutical industry, producing a variety of generic medications, including Tramadol. With a strong presence in the market, Hypermarcas has become a household name in Brazil for affordable and high-quality generic drugs.

9. Medley
Medley is a well-known pharmaceutical company in Brazil, producing a wide range of generic medications, including Tramadol. With a market share of over 10% in the generic drug segment, Medley has established itself as a key player in the Brazilian pharmaceutical market.

10. EMS Farma
EMS Farma is another subsidiary of EMS Pharmaceutical, specializing in the production of generic medications, including Tramadol. With a strong distribution network and a focus on quality, EMS Farma has become a trusted name in the Brazilian pharmaceutical market.

Insights:

The demand for generic medications like Tramadol is expected to continue growing in Brazil, driven by factors such as an aging population, increasing healthcare costs, and government initiatives to promote the use of generic drugs. According to industry reports, the Brazilian pharmaceutical market is projected to reach a value of over $40 billion by 2025, with generic drugs accounting for a significant portion of the total market share. As such, pharmaceutical companies in Brazil will need to focus on innovation, quality, and affordability to stay competitive in the evolving market landscape.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →